Eu­ro­pean Com­mis­sion so­lid­i­fies vac­cine man­u­fac­tur­ing plans to pre­pare for fu­ture health emer­gen­cies

The Eu­ro­pean Com­mis­sion struck deals with a hand­ful of con­trac­tors, in­clud­ing Pfiz­er, to se­cure “suf­fi­cient and ag­ile man­u­fac­tur­ing ca­pac­i­ties” for a va­ri­ety of vac­cine types in case of fu­ture pub­lic health emer­gen­cies.

The con­tracts are part of the com­mis­sion’s long-stand­ing goal to cre­ate a net­work of “ever-warm pro­duc­tion ca­pac­i­ties” for vac­cine and drug man­u­fac­tur­ing in Eu­rope. They were first re­port­ed by Reuters. Un­der the frame­work, the EC’s Eu­ro­pean Health and Dig­i­tal Ex­ec­u­tive Agency would have ac­cess up to 325 mil­lion vac­cine dos­es per year, it an­nounced Fri­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER